159 related articles for article (PubMed ID: 38810956)
1. Personalized ocular oncology care: how far have we come?
Jager MJ
Can J Ophthalmol; 2024 May; ():. PubMed ID: 38810956
[No Abstract] [Full Text] [Related]
2. [Ocular lymphoma : Precise diagnostics and classification as key for successful personalized treatment].
Kakkassery V; Jünemann AM; Bechrakis NE; Grisanti S; Ranjbar M; Zschoche M; Heindl LM
Ophthalmologe; 2020 Jun; 117(6):499-507. PubMed ID: 31811368
[TBL] [Abstract][Full Text] [Related]
3. Personalized medicine in ocular oncology: a brighter future for eye cancer care.
Dalvin LA
Can J Ophthalmol; 2024 Jan; ():. PubMed ID: 38228284
[No Abstract] [Full Text] [Related]
4. Personalized medicine in oncology: ethical implications for the delivery of healthcare.
Egalite N; Groisman IJ; Godard B
Per Med; 2014 Sep; 11(7):659-668. PubMed ID: 29764052
[TBL] [Abstract][Full Text] [Related]
5. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
6. Integration of art and technology in personalized radiation oncology care: Experiences, evidence, and perspectives.
Casà C; Dinapoli L; Marconi E; Chiesa S; Cornacchione P; Beghella Bartoli F; Bracci S; Salvati A; Scalise S; Colloca GF; Chieffo DPR; Gambacorta MA; Valentini V; Tagliaferri L
Front Public Health; 2023; 11():1056307. PubMed ID: 36755901
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
Riedl JM; Moik F; Esterl T; Kostmann SM; Gerger A; Jost PJ
Virchows Arch; 2024 Feb; 484(2):169-179. PubMed ID: 37982847
[TBL] [Abstract][Full Text] [Related]
8. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
9. The Development of Ocular Oncology. Watching a Dream Come True.
Shields JA; Shields CL
Asia Pac J Ophthalmol (Phila); 2017; 6(2):107-108. PubMed ID: 28399344
[No Abstract] [Full Text] [Related]
10. Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensus.
Manjandavida FP; Honavar SG; Kim U; Singh U; Menon V; Das S; Kaliki S; Palanivelu MS; Khetan V; Shah PK; Rishi P; Mulay K; Gandhi A; Vadhiraja BM; Reddy VA; Bhat S; Rao V
Indian J Ophthalmol; 2020 Jul; 68(7):1281-1291. PubMed ID: 32587152
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant - how far we have come and how much further we must go.
Agulnik A; Mahadeo KM; Steiner ME; McArthur JA
Front Oncol; 2023; 13():1148321. PubMed ID: 36910613
[No Abstract] [Full Text] [Related]
12. Patient-Centered Medical Homes in Community Oncology Practices: Changes in Spending and Care Quality Associated With the COME HOME Experience.
Waters TM; Kaplan CM; Graetz I; Price MM; Stevens LA; McAneny BL
J Oncol Pract; 2019 Jan; 15(1):e56-e64. PubMed ID: 30523764
[TBL] [Abstract][Full Text] [Related]
13. Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm.
Ridge JR
Per Med; 2006 Aug; 3(3):345-348. PubMed ID: 29788649
[TBL] [Abstract][Full Text] [Related]
14. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
15. Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit.
Alfano CM; Mayer DK; Bhatia S; Maher J; Scott JM; Nekhlyudov L; Merrill JK; Henderson TO
CA Cancer J Clin; 2019 May; 69(3):234-247. PubMed ID: 30849190
[TBL] [Abstract][Full Text] [Related]
16. [Personalized medicine in oncology].
Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
[TBL] [Abstract][Full Text] [Related]
17. N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine-A Review.
Kyr M; Svobodnik A; Stepanova R; Hejnova R
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771590
[TBL] [Abstract][Full Text] [Related]
18. Community Oncology Medical Homes: Physician-Driven Change to Improve Patient Care and Reduce Costs.
Waters TM; Webster JA; Stevens LA; Li T; Kaplan CM; Graetz I; McAneny BL
J Oncol Pract; 2015 Nov; 11(6):462-7. PubMed ID: 26220931
[TBL] [Abstract][Full Text] [Related]
19. Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital.
Bizzarri N; Nero C; Sillano F; Ciccarone F; D'Oria M; Cesario A; Fragomeni SM; Testa AC; Fanfani F; Ferrandina G; Lorusso D; Fagotti A; Scambia G
J Pers Med; 2021 Dec; 12(1):. PubMed ID: 35055317
[TBL] [Abstract][Full Text] [Related]
20. Personalized integrative oncology: targeted approaches for optimal outcomes: the 11th International Conference of the Society for Integrative Oncology.
Lee RT; Yang P; Greenlee H; Bauer-Wu S; Balneaves LG; Zick S
Integr Cancer Ther; 2015 Jan; 14(1):98-105. PubMed ID: 25505022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
